Representation in Clinical Trials

Research institutions have long struggled with accurate population representation in clinical trials. The growing proliferation of digital in healthcare ecosystems makes this more likely, but it is not perfect. UCLA Health’s Dr. Arash Naeim and Dr. Medell Briggs-Malonson share their efforts to progress the intersectionality of health technology and health audience in clinical trials and beyond. Verizon’s Robin Goldsmith and Ned Chini round out this conversation with the role devices and connectivity play in achieving representation.

Recent Episodes

Jesse Folds, Director of IT Operations and Cybersecurity at Opelousas General, discusses the growing focus on zero trust policies, cybersecurity, and the challenges of understaffed IT departments in healthcare. He highlights the importance of vendor partnerships that understand budget cycles and emphasizes shifting ROI metrics toward improving patient satisfaction and equipping nurses with tools to…

Ryan Thousand, CIO of Dahl Memorial Healthcare in rural Montana, discusses the unique challenges and opportunities of leading a critical access hospital in a small community. From leveraging AI and strategic partnerships to enhance patient care and operational efficiency, to his decision to join the Panda Health family for its vendor-agnostic, community-driven approach, Ryan shares…

For the first time in history, Texas is home to three female presidents leading Healthcare Financial Management Association (HFMA) chapters, alongside the organization’s first female CEO, Ann Jordan. This unprecedented moment is more than symbolic; it highlights a shift toward inclusivity, collaboration, and innovation in healthcare financial management. With Texas chapters spanning diverse regions…